Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 14 submissions in the queue.

Submission Preview

Link to Story

Massive controlled COVID vaccine safety study

Accepted submission by Beryllium Sphere (r) at 2021-09-02 01:46:46
Science

Journal reference: https://www.nejm.org/doi/10.1056/NEJMoa2110475 [nejm.org]

We already had safety data from samples of tens of thousands in the Phase 3 trials. What's new here is the size, and one of the increased risks is one I had not heard of before.

Israel somehow found a control group of more than 884,000 unvaccinated people. They matched them to a comparable sample of vaccinated people the same size, and asked the right question, which is does a bad thing happen more often for vaccinated people or is it just what you'd expect statistically?

"Vaccination was most strongly associated with an elevated risk of myocarditis (risk ratio, 3.24; 95% confidence interval [CI], 1.55 to 12.44; risk difference, 2.7 events per 100,000 persons; 95% CI, 1.0 to 4.6), lymphadenopathy (risk ratio, 2.43; 95% CI, 2.05 to 2.78; risk difference, 78.4 events per 100,000 persons; 95% CI, 64.1 to 89.3), appendicitis (risk ratio, 1.40; 95% CI, 1.02 to 2.01; risk difference, 5.0 events per 100,000 persons; 95% CI, 0.3 to 9.9), and herpes zoster infection (risk ratio, 1.43; 95% CI, 1.20 to 1.73; risk difference, 15.8 events per 100,000 persons; 95% CI, 8.2 to 24.2)."

Those are the risk ratios. The absolute levels are all in the per-million range, though 160 per million for herpes zoster is approaching per-thousand. That's the one I hadn't known about.

The word "neuropathy" doesn't appear when I search the paper, so maybe they've ruled it out as an effect. I know this is a real issue for someone in our Soylent community. But if they didn't include people with existing neuropathy, it sheds no light.

They also include data on the side effects of a COVID infection. Eep. To avoid that I'll raise my chance of appendicitis 40%.


Original Submission